AngioDynamics Inc (ANGO)

Name: AngioDynamics Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Instruments Supplies

Latest reporting period: 2026-02-28

Latest Quarter

2026-02-28

Revenue

$78.4M

Net Income

-$8.1M

Operating Margin

-4.8%

Free Cash Flow

-$14.6M

Debt / Assets

34.7%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for AngioDynamics Inc (ANGO).
Income Statement (Quarterly)	2026-02-28	2025-11-30	2025-08-31	2025-02-28
Revenue	78,423,000	79,433,000	75,711,000	72,004,000
Cost of Revenue	36,944,000	37,293,000	33,854,000	33,147,000
Gross Profit	41,479,000	42,140,000	41,857,000	38,857,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	38,156,000	36,862,000	40,685,000	35,994,000
Operating Expenses	45,240,000	44,630,000	52,513,000	42,907,000
Operating Income	-3,761,000	-2,490,000	-10,656,000	-4,050,000
Interest Expense	-88,000	102,000	4,000	0
Income Before Tax	-8,072,000	-6,355,000	-10,838,000	-4,409,000
Income Tax Expense	12,000	-5,000	65,000	-2,000
Net Income	-8,084,000	-6,350,000	-10,903,000	-4,407,000
Per Share
EPS	-0.19	-0.15	-0.26	-0.11
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for AngioDynamics Inc (ANGO).
Income Statement (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Revenue	292,498,000	303,914,000	338,752,000	316,219,000	291,010,000
Cost of Revenue	134,793,000	149,216,000	164,506,000	150,487,000	134,222,000
Gross Profit	157,705,000	154,698,000	174,246,000	165,732,000	156,788,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	145,227,000	143,982,000	144,252,000	133,752,000	117,224,000
Operating Expenses	197,659,000	347,133,000	192,925,000	183,949,000	171,750,000
Operating Income	-39,954,000	-192,435,000	-19,233,000	-19,007,000	-35,283,000
Interest Expense	0	0	2,702,000	688,000	861,000
Income Before Tax	-34,032,000	-191,638,000	-54,437,000	-29,949,000	-36,052,000
Income Tax Expense	-39,000	-7,289,000	-1,995,000	-3,402,000	-4,504,000
Net Income	-33,993,000	-184,349,000	-52,442,000	-26,547,000	-31,548,000
Per Share
EPS	-0.83	-4.59	-1.33	-0.68	-0.82
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for AngioDynamics Inc (ANGO).
Balance Sheet (Quarterly)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Assets
Cash and Cash Equivalents	55,893,000	76,056,000	44,620,000	28,825,000
Short Term Investments	0	0	0	0
Net Receivables	43,140,000	50,011,000	52,826,000	52,304,000
Inventory	62,006,000	60,616,000	55,325,000	51,392,000
Total Current Assets	168,324,000	193,253,000	163,542,000	143,345,000
Property Plant Equipment	32,300,000	35,666,000	44,384,000	45,005,000
Goodwill and Intangibles	69,116,000	77,383,000	270,382,000	353,438,000
Total Assets	280,144,000	317,671,000	532,637,000	552,751,000
Liabilities
Account Payables	33,291,000	37,751,000	40,445,000	28,047,000
Short Term Debt	0	4,728,000	14,761,000	8,783,000
Total Current Liabilities	76,197,000	91,155,000	83,825,000	74,324,000
Long Term Debt	0	0	49,818,000	25,000,000
Total Liabilities	97,174,000	112,085,000	154,341,000	128,262,000
Shareholders Equity
Retained Earnings	-429,197,000	-395,204,000	-210,855,000	-158,413,000
Total Shareholders Equity	182,970,000	205,586,000	378,296,000	424,489,000

Balance sheet annual history for AngioDynamics Inc (ANGO).
Balance Sheet (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Assets
Cash and Cash Equivalents	55,893,000	76,056,000	44,620,000	28,825,000	48,161,000
Short Term Investments	0	0	0	0	0
Net Receivables	43,140,000	50,011,000	52,826,000	52,304,000	37,318,000
Inventory	62,006,000	60,616,000	55,325,000	51,392,000	48,614,000
Total Current Assets	168,324,000	193,253,000	163,542,000	143,345,000	140,879,000
Property Plant Equipment	32,300,000	35,666,000	44,384,000	45,005,000	37,073,000
Goodwill and Intangibles	69,116,000	77,383,000	270,382,000	353,438,000	370,293,000
Total Assets	280,144,000	317,671,000	532,637,000	552,751,000	561,438,000
Liabilities
Account Payables	33,291,000	37,751,000	40,445,000	28,047,000	19,630,000
Short Term Debt	0	4,728,000	14,761,000	8,783,000	0
Total Current Liabilities	76,197,000	91,155,000	83,825,000	74,324,000	57,584,000
Long Term Debt	0	0	49,818,000	25,000,000	20,000,000
Total Liabilities	97,174,000	112,085,000	154,341,000	128,262,000	121,981,000
Shareholders Equity
Retained Earnings	-429,197,000	-395,204,000	-210,855,000	-158,413,000	-131,866,000
Total Shareholders Equity	182,970,000	205,586,000	378,296,000	424,489,000	439,457,000

Cash flow quarterly history for AngioDynamics Inc (ANGO).
Cash Flow Statement (Quarterly)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Operating Activities
Net Income	-33,993,000	-184,349,000	-52,442,000	-26,547,000
Depreciation & Amortization	25,800,000	27,712,000	30,873,000	29,349,000
Stock Based Compensation	9,772,000	10,529,000	11,158,000	10,692,000
Change in Working Capital	-14,112,000	14,421,000	-7,026,000	-21,047,000
Operating Cash Flow	-10,128,000	-28,158,000	78,000	-7,194,000
Investing Activities
Capital Expenditure	-4,464,000	-5,768,000	-4,352,000	-4,297,000
Investments	-4,464,000	-2,518,000	-4,352,000	-4,297,000
Investing Cash Flow	-10,178,000	123,717,000	-9,746,000	-19,307,000
Financing Activities
Debt Repayment	6,162,000	-50,000,000	-25,000,000	-5,000,000
Common Stock Issued/Repurchased	-1,670,000	752,000	1,171,000	2,683,000
Dividends Paid	0	0	0	0
Financing Cash Flow	-255,000	-64,248,000	25,420,000	7,683,000
Summary
Free Cash Flow	-14,592,000	-33,926,000	-4,274,000	-11,491,000
Net Change in Cash	-20,163,000	31,436,000	15,795,000	-19,336,000

Cash flow annual history for AngioDynamics Inc (ANGO).
Cash Flow Statement (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Operating Activities
Net Income	-33,993,000	-184,349,000	-52,442,000	-26,547,000	-31,548,000
Depreciation & Amortization	25,800,000	27,712,000	30,873,000	29,349,000	25,916,000
Stock Based Compensation	9,772,000	10,529,000	11,158,000	10,692,000	8,625,000
Change in Working Capital	-14,112,000	14,421,000	-7,026,000	-21,047,000	9,072,000
Operating Cash Flow	-10,128,000	-28,158,000	78,000	-7,194,000	24,093,000
Investing Activities
Capital Expenditure	-4,464,000	-5,768,000	-4,352,000	-4,297,000	-5,187,000
Investments	-4,464,000	-2,518,000	-4,352,000	-4,297,000	-5,187,000
Investing Cash Flow	-10,178,000	123,717,000	-9,746,000	-19,307,000	-13,711,000
Financing Activities
Debt Repayment	6,162,000	-50,000,000	-25,000,000	-5,000,000	-20,000,000
Common Stock Issued/Repurchased	-1,670,000	752,000	1,171,000	2,683,000	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	-255,000	-64,248,000	25,420,000	7,683,000	-16,986,000
Summary
Free Cash Flow	-14,592,000	-33,926,000	-4,274,000	-11,491,000	18,906,000
Net Change in Cash	-20,163,000	31,436,000	15,795,000	-19,336,000	-6,274,000